步长制药(603858.SH)：子公司签订《参附益心颗粒注册临床试验委托合同》

Core Viewpoint - Company signed a contract for clinical trial services for a new product, indicating a strategic move to advance its product pipeline and enhance market competitiveness [1] Group 1: Contract Details - The contract is between the company's subsidiary, Shandong Danhong Pharmaceutical Co., Ltd., and Beijing Excellent Future International Pharmaceutical Technology Development Co., Ltd. for the clinical trial of "Shenfu Yixin Granules" [1] - The total cost for the clinical trial is 60,338,000.00 yuan (including tax), covering 480 cases with a 20% dropout rate [1] - If the final sample size exceeds 520 cases, additional costs will be calculated at 108,890.00 yuan per case, with a supplementary agreement to be signed [1] Group 2: Cost Breakdown - The total cost includes various expenses such as CRO service fees, hospital fees, data management and statistics, SMO fees, and recruitment costs [1]